Drug shortage
Bupivacaine Hydrochloride Injection · Kindos Pharmaceuticals Co. Ltd.
FDA drug shortage · To Be Discontinued · updated May 5, 2026
Key facts
| Generic name | Bupivacaine Hydrochloride Injection |
|---|---|
| Company | Kindos Pharmaceuticals Co. Ltd. |
| Presentation | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Anesthesia |
| Package NDCs | 71288-722-32 |
| First posted | May 5, 2026 |
| Last updated | May 5, 2026 |
| Discontinued | May 5, 2026 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: